Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 21 for “"dCK"”.
-
Virtual Screening for Inhibitors of Anti-apoptotic Proteins: DCK, BCL-XL, MCL-1, MDMX, and MDM2
←Within this dissertation the topic of virtual screening is discussed with regard to three different cancer targets and also a brief introduction of the tools used in virtual screening. In Chapter 1, the reader will be introduced to virtual screening and the programs that are used in virtual …
-
Transcriptional and posttranscriptional regulation of deoxycytidine kinase
… Η έλλειψη έκφρασης ή ενεργότητας της κινάσης dCK σε κύτταρα οδηγεί σε ανθεκτικότητα των κυττάρων αυτών στα παραπάνω φάρμακα, γεγονός που υποδηλώνει ότι το ένζυμο αυτό παίζει ρόλο "κλειδί" στον μεταβολισμό τους που τουσ προσδίδει και την φαρμακολογική τους δραστικότητα. Για τους λόγους αυτούς η …
-
Διερεύνηση του προβλεπτικού και προγνωστικού ρόλου της έκφρασης των γονιδίων BRCA1, RRM1, RRM2, hENT1, dCK και CDA στον προχωρημένο μη μικροκυτταρικό καρκίνο του πνεύμονα
… transcriptional levels of RRM1, RRM2, CDA, dCK and hENT1 genes -all being involved in the intracellular activity and metabolism of gemcitabine- are potential biomarkers for the drug’s efficacy in advanced-stage NSCLC. At the same time, BRCA1 mRNA expression is a candidate molecular predictor …
-
DEVELOPMENT OF 4'-ETHYNYL-2'-DEOXYCYTIDINE (EdC), A REPLICATION-STRESS INDUCING NUCLEOSIDE ANALOG PRODRUG WITH PREFERENTIAL ACTIVITY IN LEUKEMIA AND LYMPHOMA SUBTYPES
… (ALL). EdC requires deoxycytidine kinase (dCK) phosphorylation for its activity and induces replication fork arrest and accumulation of cells in S-phase, indicating it acts as a chain terminator. A 2.1Å co-crystal structure of dCK bound to EdC and UDP reveals how the rigid 4’-alkyne of EdC …
-
Development of Novel Cell Fate Control Gene Therapy for Applications in Cancer and Immune Disorders
… variants of human deoxyCytidine Kinase (dCK), which enable robust activation of multiple Nucleoside Analogue (NA)-based prodrugs, act early in the pathway enabling rapid accumulation of activated NAs in target cells, and also provide the capabilities for the direct imaging of GMCs. Stable …
-
Synthesis and Evaluation of Novel Iodine-124 Labeled Nucleoside Analogs as Pet Imaging Agents to Predict Response to Gemcitabine Therapy
… various known biomarkers, deoxycytidine kinase (dCK) is considered to be an important rate limiting enzyme that is necessary to convert gem into its cytotoxic derivativeand therefore, levels of dCK in tumors could aid in predicting the drug’s efficacy to treat cancers and patient response to …
-
Ein neues Target zur Therapie von Basaliom und spinozellulärem Karzinom - Inhibition der humanen DNA Polymerase alpha
… hENT-1, MRP4 und MRP5 sowie der Enzyme dCK, dGK, TK-1 und TP nachgewiesen. Sowohl primäre Keratinozyten als auch HaCaT-Zellen exprimieren alle untersuchten Transporter und Enzyme. SCC-25 Zellen dagegen exprimieren den Transporter hENT-1 und das Enzym dCK kaum. Ob oder in welchem Ausmaß …
-
Group Key Management in Wireless Ad-Hoc and Sensor Networks
… For key management in WSNs, we started with DCK, a modified scheme suitable for WSNs. In summary, the DCK achieves the following: (1) cluster leader nodes carry the major part of the key management overhead; (2) DCK consumes less than 50% of the energy consumed by SHELL in key management; (3) …
-
Modeling artificial groundwater recharge and low-head hydroelectric production: a case study of southern Pakistan
DHA City Karachi (DCK), a city designed for approximately one million people, is envisaged to become a satellite city to the second largest city in the world, Karachi, which has a population of 25 million. The upcoming city is located 21 miles north of main metropolitan Karachi in the arid southern …
-
Selective variegated methylation of the p15/INK4B CpG island is a high frequency event in acute myeloid leukemia (AML)
… DNA methylation status of the 5' CpG islands of dCK containing 49 CpGs, p15 containing 80 CpGs, and p16 containing 53 CpGs was determined by sodium bisulfite sequencing of normal human peripheral blood lymphocytes (PBL) and bone marrow (NBM), human leukemia cell lines, and cytosine-arabinoside …
-
Aminorūgščių ir nukleotidų konjugatų chemofermentinė sintezė /
… of nucleotides modified with amino acid using dCK and ACK enzymes system. In total, 15 different amino acid and 2'-deoxycytidine conjugates were synthesized, five of these are new, not decribed in literature. Six N4-acyl-Boc-2'-deoxycytidines (1-6) and six N-(4-(2'-deoxycytidinyl)) amino acid …
-
Development and Application of Large-Scale Protein Folding Stability Analysis in Drug Target Identification and Disease Biomarker Discovery
… consistent protein hits, deoxycytidine kinase (DCK) and exportin-2 (XPO2), from more than 2000 assayed proteins in a 2B4T cell lysate. The binding of DCK with subglutinol A was validated using a targeted gel-based pulse proteolysis experiment. A set of chemical biology experiments were performed …
-
Integration of yeast phenomics and cancer pharmacogenomics to model precision medicine
… a humanized yeast model of deoxycytidine kinase (dCK) to resolve differential gene-drug interaction for gemcitabine and cytarabine. These structurally similar nucleoside analogs are activated by dCK, yet display remarkably different anti-tumor efficacy. We found greater influence on gemcitabine …
-
Gemcitabine pharmacogenetics and mechanisms involved in synergistic interaction of gemcitabine in combination with platinum drugs
… not associated with a significant increase in dCK gene expression, as measured by quantitative-realtime PCR. Induction of GEM-TP accumulation was not selective to GEM but seen with both cytarabine and cisplatin. This suggests that the mechanism is either due to post translational modification …
-
Investigation of Hyaluronic Acid-Functionalised pH-Sensitive Liposomes to Overcome Gemcitabine Resistance in Pancreatic Cancer: Mono- and Dual-Therapy
… RRM1 and RRM2 was up-regulated while that of dCK was down-regulated in Gr2000. Also, protein expression of dCK was found to be hardly detectable in Gr2000 in contrast to the high level in MIA PaCa-2. Therefore, in this thesis, consequently co-delivery of gemcitabine and an agent that inhibited …
-
Investigating Genomic Methods to Improve the Productivity of Canadian Dairy Goats
… (e.g., CSN1S1, DGAT1, ZNF16) and novel (e.g., DCK, MOB1B, and RPL8) positional and functional candidate genes, providing greater insight into the genetic architecture of milk production and conformation traits in these populations. Overall, these results suggest that genomic methodologies can …
-
A study of chemotherapy resistance in acute myeloid leukemia
… treatment, it was determined mutations in Dck were the primary factor in the development of Ara-C resistance in an in vitro model of Ara-C resistance. Drug screens were used to determine Ara-C resistant cells became more sensitive to glucocorticoids, and cladribine is an affective partner …
-
Investigation of Anemarrhena asphodeloides and its Constituent Timosaponin-AIII as Novel, Naturally Derived Adjunctive Therapeutics for the Treatment of Advanced Pancreatic Cancer
… in gemcitabine activation, deoxycytidine kinase (dCK), was notably increased in the cells treated with AA or TAIII compared to gemcitabine. Taken together, the results of our present study implicates AA as a significant inhibitor of PDAC cell progression as well as a potential adjunctive …
-
Prognostic factors in periampullary adenocarcinoma. A retrospective study over an 11 year period.
… and high expression of deoxycytidine kinase (dCK) indicated sensitivity to chemotherapy. In Paper IV, biomarker studies on the human epidermal growth factor receptors 1-3 (HER1-3) revealed a potential negative predictive effect of high EGFR (HER1) expression in relation to adjuvant …
-
MicroRNAs As Predictors of Nucleoside Analog Sensitivity in Acute Myeloid Leukemia
… involved in inactivation of cytarabine) and DCK (activating enzyme), respectively. These miRNAs along with other miRNAs can be used as part of biomarker signature that can be used to predict the overall survival in AML patients. In chapter IV, we determined the impact of cytarabine treatment …
Page 1 of 2